Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
81.00    -1.20 (-1.46%)
Bid:
81.20
Ask:
81.60
Spread: 0.40 (0.493%)
Market Cap: £226.96m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Chair Designate

1 Jul 2024 07:00

RNS Number : 9946T
Essentra plc
01 July 2024
 

1 July 2024

ESSENTRA PLC

("Essentra")

 

STEVE GOOD, CHAIR DESIGNATE - commencement of appointment

 

Essentra plc, a leading global provider of essential components and solutions, is delighted to confirm that further to the announcement on 23 May 2024, Steve Good has commenced his appointment as independent Non-Executive Chair Designate with effect from today, 1 July 2024.

Steve will now undergo an extensive induction, visiting Essentra's global facilities and meeting the teams as part of a four-month handover period during which Paul Lester will remain as Chair, standing down on 1 November 2024.

 

For further information please contact:

Essentra plc

Scott Fawcett, Chief Executive

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

 

 

 

LEI: 5493007MOZNA03BVNE96

 

 

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPPPUUAQUPCGUQ
Date   Source Headline
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 202511:36 amRNSHolding(s) in Company
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSAnnual Financial Report
1st Apr 20257:00 amRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20252:33 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20259:14 amRNSHolding(s) in Company
25th Mar 20259:00 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:36 amRNSTransaction in Own Shares
21st Mar 20259:09 amRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSResults for the Full Year Ended 31 December 2024
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 202511:30 amRNSNotice of Full Year 2024 Results
10th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20254:13 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20254:40 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSHolding(s) in Company
18th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.